New Nanoparticle Design For Cancer Therapy Shows Potential
9/22/2011
A new type of nanoparticle developed in the laboratories at the University of North Carolina has shown potential for more effective delivery of chemotherapy to treat cancer. Wenbin Lin, PhD, Kenan Distinguished Professor of Chemistry and Pharmacy, and colleagues report their finding in Angewandte Chemie, the German-based flagship chemistry journal...
According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate), is effective not only in decreasing tumor size but also in reducing the severity of side effects that often accompany a cancer diagnosis...
First Recurrent Gene Fusion Identified In Ovarian Cancer
9/22/2011
Researchers studying ovarian cancer have discovered that, in a substantial fraction of ovarian tumors, a gene closely related to the estrogen receptor is broken and fused to an adjacent gene by a chromosome rearrangement; a finding that could shed light on how these deadly tumors develop and spread...
Colon Cancer's Spread To The Liver Blocked By Soy Peptide/Chemo Drug Combo
9/22/2011
A University of Illinois study reports a promising new weapon in treating metastatic colon cancer, particularly in patients who have developed resistance to chemotherapy. U of I researcher Elvira de Mejia has found that the soy peptide lunasin binds to a specific receptor in highly metastatic colon cancer cells, preventing them from attaching to the liver...
For Cancer-Fighting T Cells, Stem Cells Show Potential
9/22/2011
Adult stem cells from mice converted to antigen-specific T cells - the immune cells that fight cancer tumor cells - show promise in cancer immunotherapy and may lead to a simpler, more efficient way to use the body's immune system to fight cancer, according to Penn State College of Medicine researchers...
MRI Screening For Breast Cancer Benefits High-Risk, Underserved Women
9/22/2011
Using breast magnetic resonance imaging (MRI) screenings among targeted, high-risk, underserved women significantly decreased diagnostic cost and increased patient compliance rates with follow-up compared to using general risk mammography screenings. However, a caveat to these findings was that the cost of a MRI was reduced from an average of $3,500 to $649 by a grant specific to the study...
Test Could Detect Breast Cancers Earlier In Young, High-risk African-American Women
9/22/2011
Certain cancer signaling pathways that are activated in aggressive cancer can be detected very early, even in precancerous cells, among young African-American women at high risk for breast cancer. This may allow for earlier detection and prevention of cancer...
Among Cancer Patients, Costly Blood Clots More Common Than Expected
9/22/2011
An analysis of more than 30,000 cancer patients has shown that blood clots are a more common complication than doctors may realize, causing additional hospitalizations and driving up the cost of care, according to a study led by a Duke Cancer Institute researcher. The study, which will be reported Sept...
Predicting Sexual Function After Prostate Cancer Treatment Has Improved
9/21/2011
A study published in the Sept. 21 issue of the Journal of the American Medical Association by a Beth Israel Deaconess Medical Center research team, suggests more open discussion between doctor and patient will assist in improving quality of life for prostate cancer survivors...
New Imaging Technique Highlights Cancer During Surgery
9/21/2011
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and have to undergo surgery plus chemotherapy. During the operation, surgeons attempt to remove all tumor deposits as this leads to improved patient prognosis...